Abstract 16392: The Effect of Dapagliflozin on Anemia in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of DAPA-HF

Kieran F. Docherty,Silvio E. Inzucchi,Lars Køber,Mikhail Kosiborod,Anna Maria Langkilde,Feilpe A Martinez,Olof Bengtsson,Piotr Ponikowski,Marc S. Sabatine,Mikaela SjÃ¶strand,Scott D. Solomon,Pardeep S. Jhund,John J.V. McMurray

Abstract 16392: The Effect of Dapagliflozin on Anemia in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of DAPA-HF

2020

Kieran F. Docherty
Silvio E. Inzucchi
Lars Køber
Mikhail Kosiborod
Anna Maria Langkilde
Feilpe A Martinez
Olof Bengtsson
Piotr Ponikowski
Marc S. Sabatine
Mikaela SjÃ¶strand
Scott D. Solomon
Pardeep S. Jhund
John J.V. McMurray

Background: Anemia is common and associated with worse outcomes in patients with heart failure and reduced ejection fraction (HFrEF). We examined: 1) whether dapagliflozin corrected anemia in these...

Keywords:

Anemia
Dapagliflozin
Hemoglobin
Ejection fraction
Medicine
Diabetes type ii
Internal medicine
Cardiology
in patient
Heart failure

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations